David Malcom Rodman - Oct 11, 2024 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Chief Medical Officer
Signature
/s/ Adam Levy, Attorney-in-fact
Stock symbol
MLYS
Transactions as of
Oct 11, 2024
Transactions value $
$8,489
Form type
4
Date filed
10/15/2024, 04:22 PM
Previous filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Options Exercise $2.71K +5.02K +3.99% $0.54 131K Oct 11, 2024 Direct
transaction MLYS Common Stock Options Exercise $5.78K +5.35K +4.1% $1.08 136K Oct 14, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLYS Stock Option Options Exercise $0 -5.02K -25% $0.00 15.1K Oct 11, 2024 Common Stock 5.02K $0.54 Direct F1
transaction MLYS Stock Option Options Exercise $0 -5.35K -3.13% $0.00 165K Oct 14, 2024 Common Stock 5.35K $1.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested with respect to 25% of the underlying shares on March 12, 2022, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter.
F2 The stock option vested with respect to 25% of the underlying shares on July 12, 2023, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter.